drugset / Trial / NCT00036582

Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents

NCT00036582

Phase 3 Completed 116 enrolled National Institute of Mental Health (NIMH)
Treatment

Summary

The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.

Timeline

Start
2002-05
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clozapine Other / unclassified

Indications